First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products

cobas(R) TaqScreen DPX Test offers real-time discrimination in a single assay(1)

PLEASANTON, California, October 4, 2010 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas(R)
TaqScreen DPX Test for use on the cobas s 201 system is now available with
the CE Mark. It is the first IVD test to offer complete coverage of [...]

First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products

cobas(R) TaqScreen DPX Test offers real-time discrimination in a single assay(1)

PLEASANTON, California, October 4, 2010 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas(R)
TaqScreen DPX Test for use on the cobas s 201 system is now available with
the CE Mark. It is the first IVD test to offer complete coverage of [...]

Hospira Names Svend Andersen to Lead Europe, Middle East and Africa

LEAMINGTON SPA, England, October 4, 2010 – Hospira (NYSE: HSP), a global specialty pharmaceutical and medication
delivery company, announced today that Svend Andersen has been named
corporate vice president and president, Europe, Middle East and Africa
(EMEA). In this capacity, he will be responsible for developing strategy,
delivering growth and attaining market leadership in the EMEA region.
Andersen, 48, [...]

Almac’s North American Headquarters Opens its Doors for Audits

SOUDERTON, Pennsylvania, October 4, 2010 – Almac has officially begun hosting customer audits onsite at the new
North American Headquarters. Nine companies have already been given a tour of
the new facility by Business Development staff. Almac has also hosted three
of five "audit open houses" in which multiple customers are free to attend.
The audits have been [...]

Elsevier Launches New Journal: Developmental Cognitive Neuroscience

A Journal for Cognitive, Affective and Social Developmental Cognitive Neuroscience

OXFORD, England, October 4, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and solutions, is pleased to announce the launch of a
new journal, Developmental Cognitive Neuroscience. (
www.elsevier.com/wps/find/journaldescription.cws_home/722734/descripti
on) Published quarterly, print copies of the first issue will be available at
the Society for [...]

Professor Dr. Alexander (Sandy) Lawson is Awarded the 2011 Herman Skolnik Award

NEUCHATEL, Switzerland, October 4, 2010 – Elsevier Properties SA today congratulated its Research and Development
Director, Professor Dr. Alexander (Sandy) Lawson, for receiving the 2011
Herman Skolnik Award. Presented by the American Chemical Society (ACS)
Division of Chemical Information (CINF), the award recognizes outstanding
contributions to and achievements in the theory and practice of chemical
information science and related [...]

Medtronic Announces Collaboration With Tissuemed for Exclusive Distribution of Innovative Neurosurgical Film

MINNEAPOLIS, October 4, 2010 – Medtronic, Inc. (NYSE: MDT) today announced it will distribute Obex
NeuroFilm(TM) Cerebrospinal Fluid Barrier in markets outside the US in
collaboration with Tissuemed, a leading company in the research, development,
design and manufacture of products utilizing adhesive polymer technology for
medical applications.

Under the terms of its agreement with Tissuemed, [...]

Concentric Medical Announces Product and Procedure Reimbursement as Well as Full Commercialization of the Merci Retriever(R) in Japan

MOUNTAIN VIEW, California, October 4, 2010 – Concentric Medical, Inc., the global leader in devices for clot removal
in ischemic stroke patients, today announced that the Merci Retriever(R) has
recently received both product and procedure reimbursement from the Japanese
Ministry of Health, Labor and Welfare. The Merci Retriever is a
catheter-based medical device that physicians at stroke centers [...]

ProteoTech and Tasly Pharmaceuticals Announce Alzheimer’s Disease Drug Development Agreement for Exebryl-1(R)

Potential disease-modifying Alzheimer's treatment targeting beta-amyloid and tau protein advancing through collaboration between ProteoTech Inc. and major Chinese company, Tasly Pharmaceuticals.

KIRKLAND, Washington, October 4, 2010 – Tasly Pharmaceutical Co., Ltd. (Tianjin, China) and ProteoTech, Inc.
(Kirkland, WA, USA) today announced an agreement to co-develop ProteoTech's
novel small molecule therapeutic, Exebryl-1(R), for the treatment of
mild-to-moderate Alzheimer's disease. [...]

Elsevier Online Opinion Survey Reveals Researchers Ready to Push Scientific Search and Discovery to the Next Level

AMSTERDAM, October 4, 2010 – On Tuesday, September 28, Elsevier released the results of a
"Future of Search and Discovery" opinion survey that was designed to provide
a "quick pulse" of the attitudes of researchers through an informal online
opinion poll. While it was not a scientific research study nor labeled as
such in the release, we should [...]

BridgePoint Medical(R), Inc. Completes and Submits to FDA in the U.S. FAST-CTOs With the CrossBoss(R) and Stingray(R) CTO Recanalization System

MINNEAPOLIS, October 4, 2010 – BridgePoint Medical, Inc., a medical device company focused on coronary
and peripheral catheter-based systems for chronic total occlusion (CTO)
recanalization, announced the completion of the FAST-CTOs study.
BridgePoint's 16 center, 147 patient U.S. FAST-CTOs (Facilitated Antegrade
Steering Technique for the treatment of Chronic Total Occlusions) study was
designed to assess the safety and effectiveness [...]

Sirius Genomics Receives NRC-IRAP Funding for Development of New Biomarkers

VANCOUVER, October 5, 2010 – Sirius Genomics, a developer of companion diagnostics, announced today
that it has signed its second Contribution Agreement with the National
Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).

This research funding will be applied to discovery of genomic biomarkers
that are predictive of patient response to therapeutics used [...]

Blood Pressure Pills More Effective When Taken at Night

New Research Which Shows That Timing Blood Pressure Medication With a Patient's Body Clock Make it More Effective and Offers Greater Protection Against the Occurrence of Heart Attacks and Strokes is Set to Change the Hypertension Treatment for Hundreds of Millions of People Worldwide

NEW YORK, October 5, 2010 – Chronobiology International – the international [...]

World-Check Launches Best Practice Iran Sanctions Solution – Two New Products to Help Clients Identify Iran Regulatory and Reputational Risk

Market Leader Dedicates its Unparalleled Resources to Help its 4,500+ Clients Meet Their New Requirements

LONDON, October 5, 2010 – World-Check today announced the launch of its Iran Economic Interest
(IEI) solution following a raft of new international legislation including
the U.S. Government's Comprehensive Iran Sanctions, Accountability and
Divestment Act (CISADA) of July 2010, U.N. Security Council Resolution [...]

Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer’s Disease

BROOMFIELD, Colorado, October 5, 2010 – Accera, Inc., a medical research and development company delivering
breakthrough therapies for serious diseases such as Alzheimer's disease (AD),
announced today that Thomas Werner, Ph.D., has been appointed President and
CEO. Concurrently with Dr. Werner's appointment, the U.S. Food and Drug
Administration (FDA) has accepted Accera's Investigational New Drug (IND)
application to conduct [...]

Nobel Prize for Scientist Professor Robert G. Edwards, Editor Emeritus of Reproductive BioMedicine Online

CAMBRIDGE, England, October 5, 2010 – Elsevier congratulates Cambridge scientist and Editor Emeritus of
Reproductive BioMedicine Online (RBMOnline), Robert G. Edwards, who has been
awarded with the 2010 Nobel Prize in Medicine for the development of in-vitro
fertilisation (IVF), a breakthrough that has helped millions of infertile
couples worldwide to have children. Professor Edwards, 85, started working on
IVF, [...]

Amsterdam Molecular Therapeutics Launches Equity Offering of up to EUR 15 Million

Not for release, publication or distribution in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Japan or South Africa or to US persons. This announcement is not a prospectus and is not an offer for sale of securities in the United States, Canada, South Africa, Australia, Japan or [...]

Ground Zero Pharmaceuticals Announces Expansion of Global Consulting in Somatic Cell Therapies

IRVINE, California, October 5, 2010 – GZP is pleased to announce that it has expanded its capabilities for
strategic regulatory and product development support of gene therapy and
somatic cell therapies, including treatment vaccines for cancer and other
serious or life-threatening diseases. New senior associates with expertise in
manufacturing and clinical development in these expanding areas allow GZP [...]

Elsevier Introduces Article-Based Publishing to Increase Publication Speed

Final and Citable Articles are Published Without Needing to Wait Until a Journal Issue is Complete; Speeding the Publication Process by an Average of 7 Weeks

AMSTERDAM, October 6, 2010 – Elsevier, the world-leading publisher of scientific, technical and
medical information products and solutions, announced today the launch of
Article-Based Publishing — a new publishing model that [...]

Amsterdam Molecular Therapeutics Successfully Raised EUR 14.3 m Through an Equity Issue

AMSTERDAM, October 6, 2010 – Amsterdam Molecular Therapeutics (AMT) Holding N.V. (Euronext:
AMT) announces today that it has successfully raised EUR 14.3 m in gross
proceeds through a private placement of new shares with institutional
investors, other qualifying investors who subscribed for at least EUR 50,000
per investor in various jurisdictions and the members of the Board of
Management [...]

Milestone Ruling for Alzheimer’s Disease Patients Announced

LONDON, October 7, 2010 – The National Institute for Health and Clinical Excellence (NICE) has
today announced new draft guidance which represents a significant step
towards ensuring patients with Alzheimer's disease in England and Wales
receive treatment for their condition, from the early stages of disease.

New draft NICE guidance released today recommends that
acetylcholinesterase [...]

Durban Commitment Targets Eye Care Crisis

DURBAN, South Africa, October 7, 2010 – The world is suffering a global eye care crisis according to world
leaders in vision health and development who attended the World Congress on
Refractive Error in Durban, South Africa.

A staggering 670 million are avoidably blind or vision impaired because
they don't have simple vision correction [...]

International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women

New Treatment Recommendations Urge Women and Doctors to Overcome the Taboo of Postmenopausal Vaginal Atrophy

LONDON, October 7, 2010 – To mark World Menopause Day on 18th October 2010, the International
Menopause Society (IMS) is launching new Recommendations for the management
of postmenopausal vaginal atrophy, a distressing condition that will affect
up to half of women after menopause.[1] [...]

Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment

CRAIGAVON, Northern Ireland, October 7, 2010 – The need for green, economic, robust and scaleable processes
for the synthesis of chiral APIs and intermediates prompted Almac (CPHI Booth
4F32) to build and fully integrate a biocatalysis group into its service
portfolio. Last year Almac launched carbonyl reductase, transaminase,
hydrolase, nitrilase, and nitrile hydratase enzyme screening kits and is
continuing [...]

IDEV Technologies Completes US$46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor

Proceeds to Fund Clinical Trials, New Product Development, Continued Revenue Growth

WEBSTER, Texas, October 7, 2010 – IDEV Technologies, Incorporated (IDEV), an emerging leader in the
development and commercialization of minimally invasive medical technologies,
today announced that it has completed a US$46 million Series D round of
financing, with Piper Jaffray & Co.'s Merchant Banking Fund (PJC Capital [...]

Pfizer Oncology To Present New Clinical Data Across Ten Tumor Types and Multiple Molecular Targets

Updated Study Results to be Presented on ALK inhibitor (PF-02341066) and Pan-HER Inhibitor (PF-00299804) in Non-Small Cell Lung Cancer

NEW YORK, October 7, 2010 – Pfizer Oncology will present new data across its portfolio representing
novel approaches to researching treatments for patients with rare and
difficult-to-treat cancers. These results will be presented at the 35th
European Society for [...]

2nd Call for DigestScience European Projects for a Total of 500,000 Euros

The Manipulation of Intestinal Flora: A New Challenge in the Treatment of Digestive Tract Diseases…

LOOS, France, October 7, 2010 – The DigestScience Foundation is launching a European call for tenders to
support cutting-edge research into digestive tract diseases: "Manipulation of
intestinal flora in health and disease : areas of interest include
genetically selected/modified organisms, virus, phages, parasites, [...]

Oral Tasocitinib Demonstrates Statistically Significant Response by 12 Weeks in Phase 2 Study of People With Moderate to Severe Plaque Psoriasis

Results Presented at the Annual Meeting of the European Academy of Dermatology and Venereology in Gothenburg, Sweden

NEW YORK, October 7, 2010 – Pfizer Inc. (NYSE: PFE) today announced that data from a Phase 2 efficacy
and safety study of tasocitinib (proposed INN name for CP-690,550), the
company's investigational oral JAK inhibitor, met its primary endpoint of [...]

Philips Introduces New Patient Monitoring System Enabling Easy Access to Patient Information and Facilitating Effective Care Delivery

ANDOVER, Massachusetts, October 7, 2010 – Royal Philips Electronics (NYSE: PHG, AEX: PHI) today introduced the
IntelliVue MX800 patient monitoring system, a new dimension in patient care
that provides immediate access to comprehensive patient information directly
at the monitor. In addition to displaying and recording traditional data such
as patient vital signs, the IntelliVue MX800 offers direct access [...]

Majestic MRSS Adds Focus Vision in Singapore

MUMBAI, India, October 7, 2010 – MMRSS which has been expanding its geographic footprint over the past 5
years announced the opening of qualitative research facility in Singapore.

The state of the art one way mirror facility is Focus Vision enabled and
is large enough to host Super Focus Groups (Super FG's). The [...]